Persistence and enrichment of dominant T cell clonotypes in expanded tumor-infiltrating lymphocytes of breast cancer … – Nature.com

Restifo NP, Dudley ME, Rosenberg SA. Adoptive immunotherapy for cancer: harnessing the T cell response. Nat Rev Immunol. 2012;12(4):26981.

Article CAS PubMed PubMed Central Google Scholar

Diaz-Cano I, Paz-Ares L, Otano I. Adoptive tumor infiltrating lymphocyte transfer as personalized immunotherapy. Int Rev Cell Mol Biol. 2022;370:16392.

Article CAS PubMed Google Scholar

Scheper W, Kelderman S, Fanchi LF, Linnemann C, Bendle G, de Rooij MAJ, et al. Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat Med. 2019;25(1):8994.

Article CAS PubMed Google Scholar

Lee HJ, Kim YA, Sim CK, Heo SH, Song IH, Park HS, et al. Expansion of tumor-infiltrating lymphocytes and their potential for application as adoptive cell transfer therapy in human breast cancer. Oncotarget. 2017;8(69):11334559.

Article PubMed PubMed Central Google Scholar

Zhang C, Ding H, Huang H, Palashati H, Miao Y, Xiong H, et al. TCR repertoire intratumor heterogeneity of CD4(+) and CD8(+) T cells in centers and margins of localized lung adenocarcinomas. Int J Cancer. 2019;144(4):81827.

Article CAS PubMed Google Scholar

Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, et al. Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international immunooncology biomarkers working group: part 1: assessing the host immune response, TILs in invasive breast carcinoma and ductal carcinoma in situ, metastatic tumor deposits and areas for further research. Adv Anat Pathol. 2017;24(5):23551.

Article PubMed PubMed Central Google Scholar

Poncette L, Bluhm J, Blankenstein T. The role of CD4 T cells in rejection of solid tumors. Curr Opin Immunol. 2022;74:1824.

Article CAS PubMed PubMed Central Google Scholar

Park IA, Rajaei H, Kim YA, Lee H, Lee H, Seo JH, et al. T cell receptor repertoires of ex vivo-expanded tumor-infiltrating lymphocytes from breast cancer patients. Immunol Res. 2020;68(5):23345.

Article PubMed Google Scholar

Bolotin DA, Poslavsky S, Mitrophanov I, Shugay M, Mamedov IZ, Putintseva EV, et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat methods. 2015;12(5):3801.

Article CAS PubMed Google Scholar

Bagaev DV, Vroomans RMA, Samir J, Stervbo U, Rius C, Dolton G, et al. VDJdb in 2019: database extension, new analysis infrastructure and a T-cell receptor motif compendium. Nucleic Acids Res. 2019;48(D1):D105762.

Article PubMed Central Google Scholar

Tickotsky N, Sagiv T, Prilusky J, Shifrut E, Friedman N. McPAS-TCR: a manually curated catalogue of pathology-associated T cell receptor sequences. Bioinformatics. 2017;33(18):29249.

Article CAS PubMed Google Scholar

Vita R, Mahajan S, Overton JA, Dhanda SK, Martini S, Cantrell JR, et al. The immune epitope database (IEDB): 2018 update. Nucleic Acids Res. 2019;47(D1):D339d43.

Article CAS PubMed Google Scholar

Chen SY, Yue T, Lei Q, Guo AY. TCRdb: a comprehensive database for T-cell receptor sequences with powerful search function. Nucleic Acids Res. 2021;49(D1):D468d74.

Article CAS PubMed Google Scholar

Pasetto A, Gros A, Robbins PF, Deniger DC, Prickett TD, Matus-Nicodemos R, et al. Tumor- and neoantigen-reactive T-cell receptors can be identified based on their frequency in fresh tumor. Cancer Immunol Res. 2016;4(9):73443.

Article CAS PubMed PubMed Central Google Scholar

John J, Chen SMY, Woolaver RA, Ge H, Vashisht M, Huang Z, et al. Host-specific differences in top-expanded TCR clonotypes correlate with divergent outcomes of anti-PD-L1 treatment in responders versus non-responders. Front Immunol. 2023;14:1100520.

Article CAS PubMed PubMed Central Google Scholar

Labarrire N, Gervois N, Bonnin A, Bouqui R, Jotereau F, Lang F. PBMC are as good a source of tumor-reactive T lymphocytes as TIL after selection by Melan-A/A2 multimer immunomagnetic sorting. Cancer Immunol Immunother. 2008;57(2):18595.

Article PubMed Google Scholar

Al-Kadhimi Z, Callahan M, Fehniger T, Cole KE, Vose J, Hinrichs S.Enrichment of innate immune cells from PBMC followed by triple cytokine activation for adoptive immunotherapy.Int Immunopharmacol.2022;113:109387.

Article CAS PubMed Google Scholar

Ghaffari S, Torabi-Rahvar M, Aghayan S, Jabbarpour Z, Moradzadeh K, Omidkhoda A, et al. Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy. BMC Immunol. 2021;22(1):43.

Article CAS PubMed PubMed Central Google Scholar

Ahrends T, Busselaar J, Severson TM, Bbaa N, de Vries E, Bovens A, et al. CD4(+) T cell help creates memory CD8(+) T cells with innate and help-independent recall capacities. Nat Commun. 2019;10(1):5531.

Article CAS PubMed PubMed Central Google Scholar

Ahrends T, Spanjaard A, Pilzecker B, Bbaa N, Bovens A, Xiao Y, et al. CD4(+) T cell help confers a cytotoxic T cell effector program including coinhibitory receptor downregulation and increased tissue invasiveness. Immunity. 2017;47(5):84861.e5.

Article CAS PubMed Google Scholar

John J, Woolaver RA, Popolizio V, Chen SMY, Ge H, Krinsky AL, et al. Divergent outcomes of anti-PD-L1 treatment coupled with host-intrinsic differences in TCR repertoire and distinct T cell activation states in responding versus non-responding tumors. Front Immunol. 2022;13:992630.

Article CAS PubMed PubMed Central Google Scholar

See the rest here:
Persistence and enrichment of dominant T cell clonotypes in expanded tumor-infiltrating lymphocytes of breast cancer ... - Nature.com